Podchaser Logo
Home
Practices for Preventing Polypharmacy in Multiple Sclerosis

Practices for Preventing Polypharmacy in Multiple Sclerosis

Released Wednesday, 13th March 2024
Good episode? Give it some love!
Practices for Preventing Polypharmacy in Multiple Sclerosis

Practices for Preventing Polypharmacy in Multiple Sclerosis

Practices for Preventing Polypharmacy in Multiple Sclerosis

Practices for Preventing Polypharmacy in Multiple Sclerosis

Wednesday, 13th March 2024
Good episode? Give it some love!
Rate Episode

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

Guest: Ahmed Zayed Obeidat, MD, PhD

Guest: Lauren Beranek, BS

Polypharmacy is defined as the regular use of five or more prescribed medications, and due to their disease course, related symptoms, and side effects, patients with multiple sclerosis are at an increased risk of polypharmacy. So to hear insights on ways to identify, manage, and prevent polypharmacy, Dr. Mary Catherine Cheeley is joined by Dr. Ahmed Obeidat, Associate Professor of Neurology, and Lauren Beranek, MD candidate at the Medical College of Wisconsin.

Find a full article on their findings published in Practical Neurology.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features